FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2989630537> ?p ?o ?g. }

• W2989630537 abstract "Abstract Background We sought to determine whether prenatal supplementation with the omega-3 fatty acids eicosapentaenoic acid (EPA) or docosahexaenoic acid (DHA) would increase markers of insulin sensitivity in maternal or cord blood compared with placebo supplementation. A secondary aim was to evaluate the association of serum EPA and DHA fractions with adiponectin, leptin and the adiponectin:leptin ratio (ALR). We hypothesized that omega-3 fatty acid supplementation would increase markers of insulin sensitivity in maternal and umbilical cord plasma. Methods We analyzed stored plasma samples collected from a prior 3-arm prospective, double-blinded, randomized controlled trial in which 126 women with singleton pregnancies between 12- and 20-weeks’ gestation were randomized to receive: 1) an EPA-rich fish oil supplement, 2) a DHA-rich fish oil supplement, or 3) a soy oil placebo. Maternal venous blood samples were collected at 12–20 weeks gestation (before supplementation) and at 34–36 weeks gestation. At delivery, cord blood was collected. Samples were analyzed using sandwich enzyme-linked immunosorbent assay kits to quantify leptin and adiponectin levels which were utilized to calculate the ALR, a proxy measure for insulin sensitivity. Results We found no difference in adiponectin, leptin, and the ALR between the treatment and placebo groups at baseline, after supplementation, or in umbilical cord blood. In regression analyses, higher maternal serum DHA fraction was associated with increased ALR before ( p = 0.01) and after ( p = 0.04) DHA supplementation. There was no association of EPA fraction with any measure of insulin sensitivity. Cord blood DHA fraction was significantly associated with cord plasma leptin ( p = 0.02). Early pregnancy BMI was significantly associated with maternal leptin levels at baseline and in late pregnancy ( p < 0.001) and was inversely associated with the ALR (p < 0.001). The ALR decreased significantly between the early and late pregnancy visits (p < 0.001). Pregnancy weight gain was inversely associated with the ALR (P. < 0.02). Conclusions EPA- and DHA- rich fish oil supplementation had no effect on plasma markers of insulin sensitivity. However, maternal serum DHA fraction was significantly associated with markers of insulin sensitivity. Trial registration https://clinicaltrials.gov/ , registration number NCT00711971, 7/7/2008." @default.
• W2989630537 created "2019-12-05" @default.
• W2989630537 creator A5014529404 @default.
• W2989630537 creator A5025878110 @default.
• W2989630537 creator A5057999162 @default.
• W2989630537 creator A5062610766 @default.
• W2989630537 creator A5070832842 @default.
• W2989630537 date "2019-11-29" @default.
• W2989630537 modified "2023-09-26" @default.
• W2989630537 title "Effect of prenatal EPA and DHA on maternal and cord blood insulin sensitivity: a secondary analysis of the mothers, omega 3, and mental health study" @default.
• W2989630537 cites W1847283677 @default.
• W2989630537 cites W1980704542 @default.
• W2989630537 cites W1989327865 @default.
• W2989630537 cites W2037345811 @default.
• W2989630537 cites W2050879352 @default.
• W2989630537 cites W2063035183 @default.
• W2989630537 cites W2100698037 @default.
• W2989630537 cites W2126401449 @default.
• W2989630537 cites W2130471635 @default.
• W2989630537 cites W2131984503 @default.
• W2989630537 cites W2134162846 @default.
• W2989630537 cites W2134928932 @default.
• W2989630537 cites W2155326729 @default.
• W2989630537 cites W2177838021 @default.
• W2989630537 cites W2193666498 @default.
• W2989630537 cites W2234458769 @default.
• W2989630537 cites W2265429569 @default.
• W2989630537 cites W2341738203 @default.
• W2989630537 cites W2407663233 @default.
• W2989630537 cites W2478958371 @default.
• W2989630537 cites W2480176085 @default.
• W2989630537 cites W2584970369 @default.
• W2989630537 cites W2896443019 @default.
• W2989630537 cites W2898869500 @default.
• W2989630537 cites W2906928015 @default.
• W2989630537 doi "https://doi.org/10.1186/s12884-019-2599-6" @default.
• W2989630537 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6883625" @default.
• W2989630537 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31783739" @default.
• W2989630537 hasPublicationYear "2019" @default.
• W2989630537 type Work @default.
• W2989630537 sameAs 2989630537 @default.
• W2989630537 citedByCount "2" @default.
• W2989630537 countsByYear W29896305372020 @default.
• W2989630537 countsByYear W29896305372023 @default.
• W2989630537 crossrefType "journal-article" @default.
• W2989630537 hasAuthorship W2989630537A5014529404 @default.
• W2989630537 hasAuthorship W2989630537A5025878110 @default.
• W2989630537 hasAuthorship W2989630537A5057999162 @default.
• W2989630537 hasAuthorship W2989630537A5062610766 @default.
• W2989630537 hasAuthorship W2989630537A5070832842 @default.
• W2989630537 hasBestOaLocation W29896305371 @default.
• W2989630537 hasConcept C126322002 @default.
• W2989630537 hasConcept C134018914 @default.
• W2989630537 hasConcept C142724271 @default.
• W2989630537 hasConcept C19038510 @default.
• W2989630537 hasConcept C203014093 @default.
• W2989630537 hasConcept C204787440 @default.
• W2989630537 hasConcept C27081682 @default.
• W2989630537 hasConcept C2776091944 @default.
• W2989630537 hasConcept C2776782570 @default.
• W2989630537 hasConcept C2776955114 @default.
• W2989630537 hasConcept C2777171753 @default.
• W2989630537 hasConcept C2777391703 @default.
• W2989630537 hasConcept C2778901321 @default.
• W2989630537 hasConcept C2779234561 @default.
• W2989630537 hasConcept C2779306644 @default.
• W2989630537 hasConcept C2779946292 @default.
• W2989630537 hasConcept C2780613262 @default.
• W2989630537 hasConcept C2780914630 @default.
• W2989630537 hasConcept C2909208804 @default.
• W2989630537 hasConcept C3017594256 @default.
• W2989630537 hasConcept C46973012 @default.
• W2989630537 hasConcept C505870484 @default.
• W2989630537 hasConcept C511355011 @default.
• W2989630537 hasConcept C543025807 @default.
• W2989630537 hasConcept C54355233 @default.
• W2989630537 hasConcept C55493867 @default.
• W2989630537 hasConcept C71924100 @default.
• W2989630537 hasConcept C86803240 @default.
• W2989630537 hasConceptScore W2989630537C126322002 @default.
• W2989630537 hasConceptScore W2989630537C134018914 @default.
• W2989630537 hasConceptScore W2989630537C142724271 @default.
• W2989630537 hasConceptScore W2989630537C19038510 @default.
• W2989630537 hasConceptScore W2989630537C203014093 @default.
• W2989630537 hasConceptScore W2989630537C204787440 @default.
• W2989630537 hasConceptScore W2989630537C27081682 @default.
• W2989630537 hasConceptScore W2989630537C2776091944 @default.
• W2989630537 hasConceptScore W2989630537C2776782570 @default.
• W2989630537 hasConceptScore W2989630537C2776955114 @default.
• W2989630537 hasConceptScore W2989630537C2777171753 @default.
• W2989630537 hasConceptScore W2989630537C2777391703 @default.
• W2989630537 hasConceptScore W2989630537C2778901321 @default.
• W2989630537 hasConceptScore W2989630537C2779234561 @default.
• W2989630537 hasConceptScore W2989630537C2779306644 @default.
• W2989630537 hasConceptScore W2989630537C2779946292 @default.
• W2989630537 hasConceptScore W2989630537C2780613262 @default.
• W2989630537 hasConceptScore W2989630537C2780914630 @default.
• W2989630537 hasConceptScore W2989630537C2909208804 @default.
• W2989630537 hasConceptScore W2989630537C3017594256 @default.
• W2989630537 hasConceptScore W2989630537C46973012 @default.

• next